Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nervous Tissue: Glial Cells

Nervous Tissue: Glial Cells

Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial cells that interact...

Glial Cells

Glial Cells

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

Cellular Adaptation I: Introduction and Atrophy

Cellular Adaptation I: Introduction and Atrophy

Cells can adapt to environmental changes to maintain function and avoid injury, a process called cellular adaptation. Adapted cells exist in a reversible intermediate state with changes in size, number, phenotype, metabolism, or function. These responses help cells meet altered physiological or pathological demands; for example, enlargement of breast and uterine tissues during pregnancy. Early adaptations may enhance function, but persistent stress eventually causes tissue damage.Types of...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to: Ketone Body Rescued Seizure Behavior of LRP1 Deficiency in Drosophila by Modulating Glutamate Transport.

Journal of molecular neuroscience : MN·2022

Same author

YWHAZ variation causes intellectual disability and global developmental delay with brain malformation.

Human molecular genetics·2022

Same author

Ketone Body Rescued Seizure Behavior of LRP1 Deficiency in Drosophila by Modulating Glutamate Transport.

Journal of molecular neuroscience : MN·2022

Same author

Effects of Deferasirox in Alzheimer's Disease and Tauopathy Animal Models.

Biomolecules·2022

Same author

Rationale for the development of an Alzheimer's disease vaccine.

Human vaccines & immunotherapeutics·2019

Same author

Effects of Resveratrol and Morin on Insoluble Tau in Tau Transgenic Mice.

Translational neuroscience·2018

Search research articles

Related Experiment Video

Updated: May 9, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

Sarcopenia: the gliogenic perspective.

¹ST013a, Department of Rehabilitation Sciences, Hong Kong Polytechnic University, Hong Kong.

Mechanisms of Ageing and Development

|July 9, 2013

Summary

This summary is machine-generated.

Sarcopenia, an age-associated loss of muscle mass, has a significant neurogenic component. New research suggests a gliogenic origin, involving glia and neurons, may trigger this condition.

Keywords:

Aging Glia Motor neuron Muscle Sarcopenia Schwann cells

More Related Videos

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Related Experiment Videos

Last Updated: May 9, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Area of Science:

Gerontology
Neuroscience
Muscle Physiology

Background:

Sarcopenia is an aging-associated condition characterized by chronic loss of muscle mass, often with dynapenia.
Recent studies highlight a strong neurogenic component in sarcopenia's development.
The precise mechanisms of sarcopenia remain incompletely understood.

Purpose of the Study:

To explore the neurogenic origins of sarcopenia.
To propose a novel hypothesis for sarcopenia's primary trigger.
To integrate neuroscience with myocyte and satellite cell research.

Main Methods:

Review of existing literature on sarcopenia and neurodegeneration.
Analysis of the relationship between glia, neurons, and muscle cells.
Examination of aging effects on neural and muscle tissues.

Main Results:

Sarcopenia exhibits a significant neurogenic component, suggesting a motor neuron degeneration model.
A close relationship exists between motor units, associated glia (CNS and PNS), and muscle cells.
Both neural and muscle cells are impacted by the aging process.

Conclusions:

The neurogenic hypothesis provides a plausible framework for understanding sarcopenia.
A gliogenic origin is proposed as the primary trigger for sarcopenia.
Future research should focus on the interplay between glia, neurons, and muscle in aging.